Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on Linkedin:
”Antiphospholipid Syndrome in Pregnancy: Is There a Role for Hydroxychloroquine?
In recent years, the management of obstetric antiphospholipid syndrome (APS) has evolved beyond conventional therapy.
While low-dose aspirin and LMWH remain the cornerstone, an important question emerges:
What should we do in refractory or high-risk APS?
Emerging evidence suggests:
Hydroxychloroquine (Plaquenil) exerts:
- Anti-thrombotic effects
- Modulation of aPL-mediated endothelial injury
- Reduction of placental inflammation and microthrombosis
Clinical data indicate:
- Improved live birth rates
- Reduced pregnancy complications
– particularly in refractory APS
Who may benefit most?
- Triple-positive APS
- Refractory obstetric APS
- APS associated with SLE
Clinical positioning:
Hydroxychloroquine is not first-line, but:
- A valuable adjunctive therapy
- Considered in high-risk or treatment-resistant cases
Safety profile:
- Well-established safety in pregnancy
- No proven teratogenicity
- Long-standing use in autoimmune diseases
Key message:
APS in pregnancy is not a uniform entity — it is a risk spectrum requiring precision medicine.
Hydroxychloroquine represents a strategic addition, not for all, but for those who need more than standard therapy.”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
May 18, 2026, 16:35Abdurrahmaan Ali Suei Elbuzidi: What is the Optimal Anticoagulation Monitoring Target in ECMO?
-
May 18, 2026, 16:34Serah N. Gathu: Gaining Valuable Updates on ACS Management at the Africa STEMI Conference
-
May 18, 2026, 16:34Mahmoud Alhariri: Apixaban in Hemodialysis-Treated Kidney Failure With Newly Diagnosed AF
-
May 18, 2026, 16:33Dimitrios Kontothanassis: The Role of Thermal Ablation in GSV Reflux Treatment – LIVE 2026
-
May 18, 2026, 16:32Michael Lichardi: New Publication on Complex Anticoagulation Management in Critical Care
-
May 18, 2026, 16:28Reza Shojaei: The Global Plasma-to-Ig Supply Chain
-
May 18, 2026, 16:01Abdul Mannan: The Hardest Conversations in Myelofibrosis
-
May 18, 2026, 15:57Bridging Innovation and Access at the WFH 2026 World Congress – South African Haemophilia Foundation
-
May 18, 2026, 15:55Pierre François Sabouret: Network Meta-Analysis of Antithrombotic Therapy in Ischemic Stroke Patients